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Abstract: Exogenous phospholipases have been used exten- 
sively as tools to study the role of membrane lipids in recep- 
tor mechanisms. We used in vitro quantitative autoradiogra- 
phy to evaluate the effect of phospholipase A, (PLA,) on 
N-methyl-D-aspartate (NMDA) and non-NMDA glutamate 
receptors in rait brain. PLA2 pretreatment induced a sig- 
nificant increase in a-[3H]amino-3-hydroxy-5-methyl- 
isoxazole-4-propionate ([3H]AMPA) binding in the stratum 
radiatum of the CA 1 region of the hippocampus and in the 
stratum moleculare of the cerebellum. No modification of 
[3H]AMPA binding was found in the stratum pyramidale of 
the hippocampus at different ligand concentrations. t3H]- 
Glutamate binding to the metabotropic glutamate receptor 
and the non-NbdDA-, non-kainate-, non-quisqualate-sensi- 
tive [3H]glutamate binding site were also increased by PLA, 
pretreatment. [3H]Kainate binding and NMDA-sensitive 
[3H]glutamate binding were minimally affected by the en- 
zyme pretreatment. The PLA, effect was reversed by 
EGTA, the PLA,, inhibitor p-bromophenacyl bromide, and 
Phospholipase A, (PLA,; EC 3.1.1.4; phosphatidyl- 
choline 2-acyllhydrolase) is a calcium-dependent, 
ubiquitous enz,yme whose activation leads to the re- 
lease of unsaturated fatty acids from the sn-2 position 
of membrane phospholipids (Van den Bosch, 1980). 
Increasing evid,ence suggests the involvement of PLA, 
in mechanisms underlying various aspects of neuro- 
nal function. PLA, activation and the subsequent pro- 
duction of difflerent metabolites play an important 
role in the regulation of receptor binding (Pasternak 
and Snyder, 1973; Limbird and Lefkowitz, 1975; 
Aronstam et al., 1977; Andreasen et al., 1979; Oli- 
veiraet al., 19841; Yonedaet al., 1985; Havoundjian et 
al., 1986; Massicotte and Baudry, 1990; Radja et al., 
1992), membrane transport (Saltarelli et al., 1990), 
prolonged pretreatment with heat. Bovine serum albumin 
(1%) prevented the increase in metabotropic binding by 
PLA,. Arachidonic acid failed to mimic the PLA, effect on 
metabotropic binding. These results indicate that PLA, can 
selectively modulate certain subtypes of excitatory amino 
acid receptors. This effect is due to the enzymatic activity 
but is probably not correlated with the formation of arachi- 
donic acid metabolites. Independent oftheir possible physio- 
logical implications, our results provide the first autoradio- 
graphic evidence that an enzymatic treatment can selec- 
tively affect the binding properties of excitatory amino acid 
receptors in different regions of the CNS. Key Words: Phos- 
pholipase A2-Glutamate-cu-Amino-3-hydroxy-5- 
methylisoxazole - 4-propionate - Metabotropic - Autora- 
diography. Catania M. V. et al. Phospholipase A, modu- 
lates different subtypes of excitatory amino acid receptors: 
Autoradiographic evidence. J. Neurochem. 60, 236-245 
(1993). 
neurotransmitter release (Ohmichi et al., 1989), and 
channel activation (Schwartz et al., 1988). Previous 
studies performed in telencephalic membranes indi- 
cate that PLA, can modulate the properties of the 
( R S )  - Q - amino - 3-hydroxy-5-methylisoxazole-4-pro- 
pionic acid (AMPA)/quisqualate subtype of excit- 
atory amino acid (EAA) receptors (Massicotte and 
Baudry, 1990; Baudry et al., 1991). This modulation 
has been correlated with a possible involvement of 
PLA, activation in the expression of long-term poten- 
tiation, a putative synaptic substrate of learning and 
memory (Massicotte et al., 1990, 199 1). 
EAA receptors are the principal neurotransmitter 
receptors mediating synaptic excitation in the mam- 
malian CNS. Different subtypes of EAA receptors 
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have been described on the basis of differential phar- 
macological properties, distinct mechanisms of intra- 
cellular signal transduction, different localizations in 
the CNS (Greenamyre et al., 1985; Monaghan et al., 
1989; Watkins et al., 1990), and heterogeneity of 
cloned cDNAs (Hollmann et al., 1989; Keinanen et 
al., 1990; Egebjerg et al., 1991; Masu et al., 1991; 
Moriyoshi et al., 199 1; Tanabe et al., 1992). The EAA 
receptors are generally classified into at least three 
ionotropic receptor subtypes linked to cation chan- 
nels: N-methyl-D-aspartate (NMDA), AMPA, and 
kainate (non-NMDA) receptors, named for the prefer- 
ential affinity for these agonists. Recently, however, a 
new non-NMDA receptor subtype coupled through a 
GTP-binding protein to activation of inositol phos- 
pholipid hydrolysis and inhibition of cyclic AMP 
(CAMP) formation has been discovered (the metabo- 
tropic receptor) (Sladeczek et al., 1985; Nicoletti et 
al., 1986; Sugiyama and Ito, 1987; Schoepp et al., 
1992). In autoradiographic studies, a unique gluta- 
mate recognition site, distinct from any known recep- 
tor type, has been described (Higgins et al., 1989). 
This site is non-NMDA-, non-kainate-, and non-quis- 
qualate-sensitive (NNKQ) and is transiently ex- 
pressed in the globus pallidus and thalamus during 
postnatal development (Greenamyre et al., 1990). 
We used in vitro quantitative autoradiography to 
evaluate the effect of PLA2 on the EAA receptor sub- 
types in three regions of rat brain-hippocampus, 
striatum, and cerebellum-where NMDA and non- 
NM DA receptors are widely and differentially local- 
ized. 
MATERIALS AND METHODS 
Materials 
(RS)-['HIAMPA (60 Ci/mmol) and [3H]glutamate (45- 
56 Ci/mmol) were obtained from New England Nuclear 
(Boston, MA, U.S.A.). Quisqualate, nonradioactive AMPA, 
and NMDA were obtained from Cambridge Research Bio- 
chemicals (Wilmington, DE, U.S.A.). Potassium thiocya- 
nate (KSCN) was obtained from Fisher Scientific (Fairlawn, 
NJ, U.S.A.). PLA, from porcine pancreas (600 U/mg of 
protein) and from bee venom (1000 U/mg of protein) and 
all other reagents and compounds were purchased from 
Sigma (St. Louis, MO, U.S.A.). 
Tissue preparation 
Male Sprague-Dawley rats (1 75- 195 g) were decapitated 
and the brains were quickly removed, mounted with Lip- 
shaw embedding matrix on a cryotome pedestal, and frozen 
under powdered dry ice. Twenty-micrometer-thick horizon- 
tal sections were cut on a Lipshaw cryostat and thaw- 
mounted onto gelatin-coated slides. Sections were stored for 
less than 24 h at -20°C. 
Phospholipase A2 pretreatment 
Before performing [3H]AMPA and metabotropic bind- 
ing, sections were incubated with PLA, at the indicated con- 
centrations for 20 min at 37°C in 50 mMTris-HC1 with 30 
m M  KSCN in the presence of 4 or 25 mM CaCl,, pH 8. 
Sections were then transferred to the same buffer for 10 min 
at 4"C, pH 7.2, in the presence of 2.5 mMCaC1,. For ['HI- 
kainate binding and NMDA-sensitive ['Hlglutamate bind- 
ing, 50 m M  Tris-acetate in the presence of 25 m M  CaCI,, 
pH 8, was used during pretreatment with the enzyme at 
37°C. Cold, Caz+-free Tris-acetate, pH 7.4, was then used 
for the wash. Control sections were treated following the 
same procedure in the absence of the enzyme. 
Autoradiography 
After the above-described pretreatment, the sections were 
immersed in incubation buffer at 4°C with tritiated ligand 
and appropriate blocking agents for 45 min. After incuba- 
tion, sections were rinsed quickly three times with cold 
buffer, then rinsed with cold 2.5% (vol/vol) glutaraldehyde 
in acetone and blown dry under a stream of hot air. The 
rinsing/drying procedure took no more than 10 s. Slides 
were placed in x-ray cassettes with appropriate radioactive 
standards and apposed to tritium-sensitive film (Hyperfilm, 
Amersham Corporation), then stored at 4°C for varying 
lengths of time. Films were developed in Kodak D-19 and 
analyzed using the MCID image processing system (Imag- 
ing Research, St. Catharines, Ontario, Canada). Ten to 
twenty-five readings were averaged for each region. Film 
density was converted into bound radioactivity using a 
computer-generated polynomial regression curve derived 
from the radioactive standards. A computer algorithm with 
higher resolution was used to measure film density in the 
stratum pyramidale of the hippocampus. 
For [3H]AMPA binding, after pretreatment with/without 
PLA,, slides were incubated for 45 min at 4°C in 50 mM 
Tris-HCI containing 2.5 mMCaCl,, 30 M K S C N ,  pH 7.2, 
in the presence of different concentrations (2,5,30, and 500 
nM) of [3H]AMPA (specific activity, 60, 50, and 2.7 Ci/ 
mmol). Nonspecific binding was defined as [3H]AMPA 
binding occurring in the presence of 1 mM unlabeled gluta- 
mate. 
We also examined the putative metabotropic receptor us- 
ing a recently described quantitative autoradiographic assay 
(Cha et al., 1990). Briefly, slides were incubated for 45 rnin 
in 50 m M  Tris-HC1, pH 7.2, containing 2.5 mM CaCl,, 30 
mM KSCN, and 100 nM [3H]glutamate (specific activity, 
45-56 Ci/mmol) in the presence of 100 pMNMDA and 10 
FM AMPA at 4°C. Nonspecific binding was determined by 
the addition of 2.5 pM quisqualate. 
For ['Hlkainate and NMDA-sensitive [3H]glutamate 
binding, sections were incubated for 45 min at 4°C in 50 
mM Tris-Ac, pH 7.4, containing 65 n M  ['Hlkainate (spe- 
cific activity, 7.8 Ci/mmol) or 65 nM [3H]glutamate (spe- 
cific activity, 45-56 Ci/mmol), 2.5 pLM quisqualate, and I 
pM kainate. Nonspecific binding was defined by the addi- 
tion of 100 pM kainate and 1 m M  NMDA, respectively. 
A unique [3H]glutamate binding site has been described, 
the NNKQ site (Higgins et al., 1989; Greenamyre et al., 
1990). Sections were incubated for 45 rnin with 65 nM [3H]- 
glutamate (specific activity, 45-56 Ci/mmol) in 50 m M  
Tris-HC1, pH 7.2, containing 2.5 mM CaC1, and 30 mM 
KSCN in the presence of 100 p M  NMDA, 2.5 pM quisqua- 
late, and 1 pM kainate. Nonspecific binding was obtained 
by adding I mM glutamate. 
RESULTS 
13H]AMPA binding 
Prewash conditions. [3H]AMPA binding was per- 
formed using different concentrations of [3H]AMPA: 
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TABLE 1. Variation of conditions during the prewash affects /3H]AMPA binding [p = 0.0001 by two-way analysis of 
variance (ANOVA); magnitude = -20%] and NMDA-sensitive [3H]glutamate binding (p = 0.0001 by two-way ANOVA; 
magnitude = +32%) but not metabotropic binding (p = 0.1 by two-way ANOVA) 
AMPA binding Metabotropic binding NMDA binding 
4"C, pH 7.2, 37"C, pH 8, 4"C, pH 7.2, 3 7 T ,  pH 8, 3 7 T ,  pH 8, 









24.1 f 2.86 
31.9 f 3.17 
22.4 f 1.60 
20.0 f 3.00 
17.9 f 1.81 
13.5 f 2.1 
1.42 f 0.25 
9.75 4 0.62 
18.9 2 1.54 
24.6 i- 1.52" 
18.9 k 1.61 
16.5 i- 2.23 
14.8 & 1.65 
10.7 2 0.71 
1.39 f 0.28 
7.43 t 1.44 
0.90 f 0.06 
0.72 2 0.07 
0.71 +- 0.15 
0.70 i- 0.08 
0.76 f 0.10 
1.28 f 0.17 
0.55 f 0.12 
I .02 i- 0.36 
0.94 -t 0.15 
0.80 f 0.1 1 
0.86 f 0.10 
0.70 i- 0.09 
0.75 rt 0.08 
1.49 f 0.15 
0.58 i- 0.04 
0.93 k 0.22 
1.60 f 0.30 
1.75 f 0.29 
1.47 & 0.21 
1.02 20.18 
1.00 t 0.19 
0.07 f 0.03 
0.26 f 0.08 
0.49 f 0.01 
2.10 & 0.1 I"  
2.21 f 0.06" 
1.90 f 0.20" 
I .30 k 0.08" 
1.31 i- 0.07 
0.04 * 0.03 
0.50 f 0.05 
0.80 2 0.1 1 
('HIAMPA binding was carried out in 500 nM ['HIAMPA (sp act, 2.7 Ci/mmol). All values are expressed as pmol/mg of protein. DG, 
dentate gyrus; C A I  SR, stratum radiatum of the CAI region of the hippocampus; CAI SO, stratum oriens of the CAI region of the 
hippocampus; CA3 SR, stratum radiatum of the CA3 region of the hippocampus; CA3 SO, stratum oriens of the CA3 region of the hippocam- 
pus; CB MOL, cerebellar molecular layer; CB GCL, cerebellar granular cell layer; STR, striatum. Results represent the mean 4 SD for three 
(AMPA) and four (metabotropic and NMDA) animals in separate experiments for each assay. 
p < 0.05 by Tukey's (a)  test. 
2, 5, 30, and 500 &(the latter had a specific activity 
of 2.7 Ci/mmol). The possibility that the prewash per- 
formed under different conditions could modify the 
results of binding studies was tested. Pretreatment at 
37"C, pH 8, in the presence of 25 mMCaC1, led to a 
slight decrease in 13H]AMPA binding in all regions 
examined (80'k of 13H]AMPA binding performed on 
standard prewash condition-pretreated sections: 4"C, 
pH 7.2, and 2.5 mM CaCl,) when experiments were 
carried out at 500 nM (Table 1). The different pre- 
wash conditions did not affect [3H]AMPA binding 
when it was performed at 5 nM [3H]AMPA (data not 
shown). 
Regional distribution. The regional distribution of 
[3H]AMPA binding was similar to the localization 
found by other authors (Nielsen et al., 1988). The 
highest amounts of binding were detected in the den- 
tate gyrus and in the strata radiatum and oriens of the 
hippocampus i(Tab1e I). However, a different pattern 
of distribution of [3H]AMPA binding was found in 
the hippocampus when extreme concentrations of li- 
gand were used to study the high- and low-affinity 
binding sites selectively. More binding was detected 
in the stratum pyramidale of the hippocampus than 
in the strata radiatum and oriens at 2 and 5 nM con- 
centrations of ligand (1 24 and 1 15%, respectively, of 
the binding in .the stratum radiatum). In contrast, less 
binding (57% of the stratum radiatum) was detected 
in the stratum pyramidale at 500 nM (Fig. 1). 
PLA, eflect. PLA,'s from porcine pancreas and 
from bee venom were used. Pretreatment with PLA, 
from porcine pancreas (0.008-0.08 U/ml) increased 
the low-affinity (500 nM) component of [3H]AMPA 
binding. Post hioc painvise Tukey's (a) test revealed a 
significant increase only in the stratum radiatum of 
the CA 1 (34%) at 0.08 U/ml PLA,. A consistent, but 
not statistically significant increase in binding was 
caused by 0.08 U/ml PLA, in the CA3 region of the 
hippocampus (39%) and in the molecular layer of the 
cerebellum (3 1 %), whereas binding in the stratum pyr- 
amidale of the hippocampus, the striatum, or the 
granular cell layer of the cerebellum was not affected 
(Fig. 2A and B). Pretreatment with porcine pancreatic 
PLA, (0.05 U/ml) did not modify the high-affinity 
component (5 nM) in any region (Fig. 3A and B). 
The pretreatment of the sections with PLA, from 
bee venom (0.5 U/ml) induced a significant increase 
in [3H]AMPA binding in the strata radiatum and ori- 
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binding in the hippo- 
campus at 2 nM (A) and 500 nM (B). CAl SR, stratum radiatu-m of 
the CAI region of the hippocampus; CA1 SP, stratum pyramidale 
of CA1 region of the hippocampus; CAI SO, stratum oriens of the 
CAI region of the hippocampus. Columns represent the mean 
f SD values of four animals. p i 0.001 by one-way ANOVA; 
'post hoc Scheffe F-pairwise comparison. 
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40 PLAZ (0.08 U/ml) 
nM and 34% at 30 nM) and in the molecular layer of 
the cerebellum (98% at 2 nM and 34% at 30 nM). 
13H]AMPA binding was not modified by the same 
pretreatment in the stratum pyramidale of the hippo- 
campus, the striatum, or the granule cell layer of the 
cerebellum. 
Metabotropic binding 
Increased temperature (37 "C instead of 4"C), basic 
pH (8 instead of 7.2), and CaCI, concentration (25 
mM) during the prewash failed to alter metabotropic 
binding (Table 1) .  Pretreatment of the rat brain slices 
with PLA, from porcine pancreas led to a significant 
increase in metabotropic binding at concentrations of 
0.1 U/ml but not lower (Fig. 4). Although a certain 
increase in binding was detected in the hippocampus 
(30%), only in the striatum (50%) did the post hoc 
comparison test reach statistical significance (Fig. 4). 
PLA, from bee venom induced a significant in- 
crease in binding in the hippocampus and in the mo- 
FIG. 3. PLAp (porcine pancreas) does 
not affect r3H]AMPA specific binding to 
high-affinity binding sites (5 nM PHI- 
AMPA) in any region examined ( p  > 0.5 
by two-way ANOVA) (A). Analysis of 
the same film using a computer algo- 
rithm with a higher resolution confirmed 
no increase also in the stratum pyrarni- 
dale of the hippocampus (p  =. 0.5 by 
two-way ANOVA) (B). DG, dentate 
gyrus; CA1, CA1 region of the hippo- 
campus; CA3, CA3 region of the hippo- 
campus; SR, stratum radiatum; SO, 
stratum oriens; CB MOL, cerebellar mo- 
lecular layer; CB GCL, cerebellar granu- 
lar cell layer; STR, striatum. PLA, pre- 
treatment carried out at 25 mM CaCI,. 
Columns represent the mean ? SD val- 
ues of four animals. 
FIG. 2. PLA, (porcine pancreas) effect 
on [3H]AMPA specific binding to low-af- 
finity binding sites (500 nM [3H]AMPA) 
( p  i 0.001 by two-way ANOVA; magni- 
tude = 20% at 0.008 U/ml PLA, and 
26% at 0.08 U/ml PLA,). *PLA pretreat- 
ment in individual region is different 
from control [ p  < 0.05 by Tukey's (a) 
test] (A). Using a computer algorithm 
with a higher resolution, no increase 
was revealed in the hippocampal pyra- 
midal layer by PLA, [ p  < 0.05 by two- 
way ANOVA; ' p  < 0.05 by Tukey's (a) 
test] (B). DG, dentate gyrus; CA1, CAI 
region of the hippocampus; CA3, CA3 
region of the hippocampus; SR, stra- 
tum radiatum; SO, stratum oriens; CB 
MOL, cerebellar molecular layer; GB 
GCL, cerebellar granular cell layer; 
STR, striatum. PLA, pretreatment 
carried out at 25 mM CaCI,. Columns 
represent the mean k SD values of four 
animals. 
lecular layer of the cerebellum only at concentrations 
above 0.5 U/ml. No increase was found in the granule 
cell layer of the cerebellum (Table 2). 
PHlKainate and NMDA-sensitive 13H]glutamate 
binding 
Pretreatment without PLA, at 37"C, pH 8, in the 
presence of 25 mM CaC1, increased binding of t3H]- 
glutamate to the NMDA receptor in every region ex- 
cept the cerebellar molecular layer, where binding was 
negligible (Table 1). A slight increase in 13H]kainate 
and NMDA-sensitive [3H]glutamate binding (9%) 
was caused by PLA2 pretreatment at the concentra- 
tions indicated (Table 3). Statistical analysis with post 
hoc Tukey's (a) test indicated that the increase in [3H]- 
kainate binding was due to a main effect in the stra- 
tum lucidum of the CA3 region of the hippocampus. 
No main regional effect was revealed by post hoc test 
for NMDA-sensitive [3H]glutamate binding. At 
higher concentrations (0.9 U/ml) no further increase 
A 
1.2 -I I 
B 
2.0 I CONTROL H PLAZ (0.05 U/ml) 
v1 
z 5 U 
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CONTROL 
H PLA2 (0.01 U/ml) 
PLAP(O.lU/ml) I 
FIG. 4. Effect of PLA, (porcine pancreas) pretreatment on metab- 
otropic binding (p  < 0.001 by two-way ANOVA; magnitude 
= 24% for 0.1 U/ml PLA,). *PLA, pretreatment in individual region 
is different from control [ p  < 0.05 by Tukey's (a) test]. DG, den- 
tate gyrus; CAI, CA1 region of the hippocampus; CA3, CA3 re- 
gion of the hippocampus; SR, stratum radiatum; SO, stratum or- 
iens; CB MOL, cerebellar molecular layer; CB GCL, cerebellar 
granular cell layer; !STR, striaturn. PLA, pretreatment carried out 
at 25 mM CaCI,. Columns represent the mean & SD values of 
four animals. 
in NMDA-sensitive [3H]glutamate binding was de- 
tected in any region (data not shown). 
NNKQ 13H]glutamate binding site 
PLA, pretreatment (bee venom, 0.5 U/ml) in- 
creased binding, to the NNKQ site. Significant in- 
creases (50%) were observed in the dentate gyrus and 
the stnatum (Table 2). 
Characterizatioii of PLA, enzymatic activity 
PLA, is a callcium-dependent enzyme. The addi- 
tion of EGTA ( I0 mM) to the preincubation buffer to 
chelate the calcium (4 mM) prevented the enzyme's 
enhancing effect on binding (Fig. 5A). p-Bromophen- 
acyl bromide (p BPB) is an alkylating agent that inacti- 
vates PLA, by acting at the catalytic site on the en- 
zyme (Volwerk et al., 1974). After treatment with 
pBPB (100 p M )  for 8 h at 0°C in calcium-free me- 
dium, PLA, lost the ability to increase metabotropic 
binding (Fig. 5A). 
PLA, is an enzyme that is quite difficult to denature 
(Brockerhoff and Jensen, 1974). However, heat pre- 
treatment of the enzyme (100°C for 30 min) blocked 
its ability to increase metabotropic binding (Fig. 5B). 
Exposure of PLA,-pretreated slices to 1% bovine 
serum albumin (BSA), which binds fatty acids (Good- 
man, 1958), prevented the activation of metabotropic 
binding normally induced by PLA, (Fig. 6A). The 
main product generated by PLA, activation is arachi- 
donic acid. Thus, the sections were exposed to arachi- 
donic acid (300 pM- 1 mM) either in the presence or 
in the absence of the enzyme. Arachidonic acid failed 
to increase metabotropic binding but, when added in 
the presence of PLA,, completely reversed the incre- 
ment in binding (Fig. 6B), in accord with its ability to 
inhibit the enzyme (Dennis et al., 1989). 
DISCUSSION 
The present autoradiographic study indicates that 
PLA, pretreatment can selectively modify AMPA 
and metabotropic receptors without considerably af- 
fecting NMDA and kainate receptors. In fact, at simi- 
lar concentrations of PLA, (0.05-0.09 U/ml), the ef- 
fect on [3H]AMPA binding and metabotropic binding 
was much higher than the effect on [3H]kainate- and 
NMDA-sensitive [3H]glutamate binding. A selective 
action of PLA, on AMPA receptors, but not on 
NMDA and kainate receptors, has been shown in tel- 
encephalic membranes (Massicotte et al., 1990). Our 
results are in accord with this previous report, because 
it is conceivable that such a modest increase in 
NMDA and kainate binding is detectable only with 
autoradiography . 
The use of an autoradiographic technique allowed 
us to elucidate interesting differences in the regional 
regulation of AMPA receptors by PLA,. Two [3H]- 
TABLE 2. PL.4, (bee venom) effect on metabotropic binding (p = 0.0001 by two-way ANOVA; magnitude = +45%) and 




Control PLA, (0.5 U/ml) 
NNKQ binding 









1.36 -+ 0.02 
1.34 -+ 0.22 
1.38 f 0.06 
1.32 f 0.07 
1.34 f 0.13 
1.94 f 0.08 
0.84 f 0.06 
I .33 -+ 0.2 
1.85 f 0.02" 
2.04 +- 0.04" 
2.24 f 0.17' 
2.26 +- 0. I" 
2.27 k 0.19" 
3.39 k 0.34" 
0.96 f 0.23 
2.00 f 0.12" 
0.98 f 0.28 
0.71 f 0.19 
0.75 ir 0.18 
0.52 f 0.15 
0.48 k 0.15 
0.25 f 0.13 
0.16 f 0.14 
0.94 f 0.28 
1.5 S 0.16" 
1.03 f 0.12 
1.09 f 0.13 
0.64 f 0.07 
0.61 t 0.08 
0.39 f 0.09 
0.21 -+ 0.05 
1.48 +- 0.10" 
All values are expressed as pmol/mg of protein. Abbreviations as in the first footnote to Table 1. PLA, pretreatment canied out at 4 m M  
CaCI, (metabotropic binding) and 25 mMCaC1, (NNKQ binding). Results represent the mean ? SD for four animals in separate experiments 
for each assay. 
a PLA, Pretreatment in individual region is different from control [ p  < 0.05 by Tukey's (a) test]. 
J. Neumchem., Vol 60, No. 1, 1993 
PHOSPHOLIPASE A2 EFFECT ON NON-NMDA RECEPTORS 241 
TABLE 3. PLA, (porcine pancreas) pretreatment minimally affects "'Hjkainate binding 
to kainate receptors (p = 0.001 by two-way ANOVA; magnitude = 9%) and 
["ll]glutamate binding to NMDA receptors [p = 0.004 











Control (0.08 U/ml) 
1.04 k 0.06 
0.54 f 0.05 
0.60 f 0.06 
2.36 rt 0.13" 
0.49 f 0.03 
1.02 f 0.05 
1.12 f 0.06 
0.99 -r- 0.1 
0.44 rt 0.10 
0.51 f 0.03 
2.21 rt 0.09 
0.47 i 0.05 
0.95 f 0.04 
1.02 f 0.09 
NMDA binding 
PLA, 
Control (0.09 U/ml) 
2.33 t 0.12 
2.43 2 0.24 
2.14 rt 0.2 1 
0.07 & 0.01 
0.39 i 0.07 
1.34 t 0.18 
2.12 t 0.1 1 
2.20 ? 0.06 
1.90 i 0.20 
0.04 +- 0.03 
0.50 i 0.04 
1.25 2 0.08 
ND ND 
All values are expressed as pmol/mg of protein. CA3 SL, stratum lucidum of the CA3 region of the 
hippocampus; ND, not determined. Other abbreviations as in the first footnote to Table 1. Results 
represent the mean k SD for four animals in separate experiments for each assay. 
PLA, pretreatment in individual region is different from control [ p  < 0.05 by Tukey's (a) test]. 
AMPA binding sites, with a high and a low affinity, 
have been described in the presence of KSCN in rat 
forebrain membranes (Honor6 and Drejer, 1988). In 
autoradiographic studies the existence of two differ- 
ent binding sites in the presence of KSCN has been 
confirmed repeatedly (Nielsen et al., 1988; Makowiec 
et al., 1991; Cha et al., 1992). In rat brain, a KD of 14 
nM and B,,, of 1.9 pmol/mg of protein for the high- 
affinity site and a K D  of 1 yMand Bm,, of 2 1 pmol/mg 
of protein for the low-affinity site have been found in 
the molecular layer of the cerebellum (Cha et al., 
1992). Similar results were obtained for the stratum 
radiatum of the hippocampus, where saturation data 
indicated a KD of 3 1.3 &and B,,, of 6.1 pmol/mg of 
protein for the high-affinity site and a KD of 2.6 pM 
and B,, of 69 pmol/mg of protein for the low-affinity 
site (unpublished observations). According to these 
values we chose extreme concentrations to estimate 
low- and high-affinity binding (2-5 and 500 nM). The 
percentage contribution of the high- and low-affinity 
components of [3H]AMPA binding at equilibrium is 
about 90 and 10% at 2 nM and 80 and 20% at 5 nM 
but 20 and 80% at 500 nM. It has been suggested that 
these two sites represent different conformational 
states of the same receptor (Honor6 and Drejer, 
1988). No difference in the relative distribution of the 
two binding sites has been found previously. Surpris- 
ingly, at 500 nM [3H]AMPA we observed lower levels 
of binding in the stratum pyramidale of the hippo- 
campus compared to the stratum radiatum. A differ- 
ent pattern of binding was detected in the hippocam- 
pus at low concentrations of ligand (2-5 nM). The 
latter concentrations favor binding to the high-affin- 
ity site. 
A B 
FIG. 5. A pBPB (1 00 pM) and EGTA (1 0 mM) 
prevent PLA, (bee venom) enhancement of 
metabotropic binding in the cerebellar molecu- 
lar layer. Enzymatic pretreatment was per- 
formed in 4 mM CaCI,. Similar results were 
found in the other regions examined. Columns 
represent the mean f SD values of four ani- 
mals. p < 0.01 by one-way ANOVA; p < 0.05 
by post hoc Scheffe f-pairwise comparison. 
B: Heat treatment abolishes PLA, (bee venom) 
enhancement of metabotropic binding in the 
cerebellar molecular layer. PLA, pretreatment 
carried out at 25 mM CaCI,. Similar results 
were found in the other regions examined. Col- 
umns represent the mean +. SD values of four 
animals. p < 0.001 by one-way ANOVA; *p 
< 0.05 by Scheffe F-post hoc pairwise com- 
parison. 
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A B 
4.0 * PLAZ(O.S u/ml) FIG. 6. A. BSA (1%) prevents PLA, (bee venom) en- 
hancement of metabotropic binding in the cerebellar 
molecular layer. Similar results were found in the 
out at 25 mM CaCI,. Columns represent the mean 
ANOVA; *p < 0.05 by Scheffe F-post hoc pairwise 
comparison. B: Arachidonic acid (ARA) does not af- 
tect metabotropic binding in the cerebellar molecular 
pic binding. Similar results were found in the other 
regions examined. Enzymatic pretreatment was per- 
i SD values of four animals. p < 0.001 by one-way 
0 
5 23.0 
l o  
other regions examined. PLA, pretreatment carried 
0 'g 
Z L  ri- SD values of four animals. p < 0.001 by one-way 
8 3 $ 3 1.0 - 
layer but prevents PLA, enhancement of metabotro- 
formed in 4 mM CaCI,. Columns represent the mean 




!? Z Z Z E  g g - -  d $ d e 
We observed that pretreatment with PLA, from 
porcine pancreas appeared to increase the low-affinity 
binding sites in the stratum radiatum without affect- 
ing the high-affinity binding sites. In addition, in the 
hippocampal pyramidal layer no significant effect of 
PLA, was observed on either high- or low-affinity 
binding sites. When the bee venom enzyme was used, 
an increase in the binding at 2 and 30 nM was ob- 
served, suggesling the possibility that both the high- 
and the low-affinity binding sites were affected by 
PLA,. Furthermore, bee venom PLA, increased bind- 
ing in the same regions affected by porcine PLA,, in- 
dicating that the biochemical effect on the receptors 
was the same for both enzymes. The differences ob- 
served using porcine and bee venom PLA, may be 
because we used lower concentrations of porcine 
PLA,. A differential sensitivity to the action of PLA, 
at different concentrations has been shown for differ- 
ent ligand binding sites on the y-aminobutyric acid, 
(GABA,) receptor complex (Havoundjian et al., 
1986). It is possible that the high-affinity binding site 
is less sensitive to PLA,, and at higher concentrations 
of PLA, both sites would be affected. The different 
pattern of distribution in the hippocampus and the 
differential response to PLA, suggest the possibility 
that the two sites represent separate receptors. On the 
basis of our results, however, we cannot exclude the 
possibility that low- and high-affinity AMPA binding 
sites represent two conformational states of the same 
protein whose molecular properties and interaction 
with the lipid1 environment change in the different 
layers of the hippocampus. The high levels of low-af- 
finity binding sites in the stratum radiatum and in the 
stratum oriens of the hippocampus and the sensitivity 
to lower concentrations of PLA, support the hypothe- 
sis that the low-affinity binding sites represent the 
physiological receptor. Our suggestion is in accord 
with the report that, in the molecular layer of the cere- 
bellum of mice lacking Purkinje cells, only the low-af- 
finity binding sites are reduced (Makowiec et al., 
1991). 
PLA, pretreatment is accompanied by a marked 
increase in metabotropic binding. As the metabotro- 
pic specific binding is an indirect measure derived 
from [3H]glutamate binding performed in the pres- 
ence of NMDA (100 p M )  and AMPA (10 pM),  the 
increase in metabotropic binding that we observed in 
the presence of PLA, could potentially be ascribed to 
the increase in AMPA binding. However, no increase 
in metabotropic binding was detected at concentra- 
tions of PLA, from porcine pancreas (0.0 1 U/ml) that 
are partially active on [3H]AMPA binding. In addi- 
tion, a significant increase in metabotropic receptor 
binding was found in the striaturn, where there is no 
modification of [3H]AMPA binding. Metabotropic 
receptors appear to be less sensitive than AMPA re- 
ceptors to the PLA, effect. In particular, metabotropic 
receptors localized in the cerebellum seem to be less 
sensitive to the membrane modification operated by 
the enzymatic treatment than metabotropic receptors 
localized in the striatum. Different subtypes of meta- 
botropic receptors with distinct localizations in the 
brain have been discovered recently (Tanabe et al., 
1992). The regional difference in receptor sensitivity 
might be explained by the existence of different recep- 
tor subtypes or by a differential chemical composition 
of neuronal membrane in discrete brain regions. In 
addition to metabotropic and AMPA receptors, the 
unique NNKQ ['H]glutamate binding site, insensi- 
tive to NMDA (1 00 p M ) ,  kainate (1 pM) ,  and quis- 
qualate (2.5 p M ) ,  was also modulated by PLA,. The 
nature of this binding site is obscure and its role in 
synaptic transmission is still unknown. 
Exogenous PLA,'s from various sources have been 
used extensively to study how changes in the lipid 
environment affect the binding and functional proper- 
ties of membrane-associated receptors (for a review 
see Loh and Law, 1980). In some of these studies 
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PLA, concentrations effective on binding were lower 
(0.5-10 mU/ml) than those used in our study (Barden 
and Labrie, 1973; Pasternak and Snyder, 1973; Azhar 
et al., 1976). In other studies, however, PLA, concen- 
trations up to 1-5 U/ml were used (Limbird and Lef- 
kowitz, 1975; Aronstam et al., 1977; Saltarelli et al., 
1990). It is possible that intact sections, instead of ho- 
mogenates, require higher concentrations of enzyme. 
Recently, however, a very strong decremental effect 
on binding has been shown for 5-hydroxytrypta- 
mine,, receptors with 0.008 U/ml PLA, in a quanti- 
tative autoradiographic study (Radja et al., 1992). In 
our study, the same concentrations produced a mod- 
est, although not significant, increase in AMPA bind- 
ing and did not affect metabotropic binding. In addi- 
tion, concentrations of PLA, from porcine pancreas 
and bee venom active on AMPA binding performed 
in homogenates are consistent with the concentra- 
tions used in our study (Massicotte and Baudry, 1990; 
Baudry et al., 1991). Thus, more than different bind- 
ing techniques, an intrinsic resistance of EAA recep- 
tor binding properties to modifications of the mem- 
brane lipids might account for this discrepancy. It has 
been demonstrated that the chloride channel of the 
GABA, receptor is much more sensitive to the PLA, 
effect than the binding to the constituent recognition 
sites (Havounjian et al., 1986). Thus, on the basis of 
our binding study, we cannot exclude the possibility 
that EAA receptor function might be affected by 
lower concentrations of PLA,. 
Calcium is an essential cofactor for the catalytic ac- 
tivity of PLA,. The ion is bound to the porcine pancre- 
atic enzyme-the best characterized among extracel- 
lular PLA,’s from various sources-with an affinity 
constant of about 4 m M  at pH 7-8 (De Haas et al., 
1971). CaC1, concentrations ranging from 10 to 100 
mM are generally used in enzymatic assays (Nieu- 
wenhuizen et al., 1974; De Geus et al., 1987; Bekkers 
et al., 1991). Therefore, a CaC1, concentration of 25 
mM was chosen to obtain the full activity of the por- 
cine enzyme on membrane phospholipids, after dem- 
onstration that such a high CaCl, concentration did 
not enhance binding to metabotropic and AMPA re- 
ceptors per se. When PLA, from bee venom was used, 
however, some experiments were performed also at a 
lower CaC1, concentration (4 mM). Variation of the 
CaCI, concentration did not affect the action of PLA, 
from bee venom (data not shown) and allowed us to 
use reasonable concentrations of EGTA to block enzy- 
matic activity. 
It is interesting to note that different prewash con- 
ditions have a significant opposite effect on AMPA 
and NMDA binding. It is possible that the increase in 
NMDA binding is due to the more effective removal 
of endogenous glutamate at 37 than at 4°C. Explain- 
ing the effects of different prewash conditions on 
AMPA binding is more difficult. The decrease we ob- 
served could be ascribed to the removal of an endoge- 
nous inhibitor or to a modification of the structural 
properties of the AMPA receptor. 
The effect of PLA, is probably due to its enzymatic 
activity because the addition of EGTA at concentra- 
tions that chelate calcium in the incubation buffer 
blocked the effect of PLA, on binding. In addition, 
heat- and pBPB-treated PLA,’s were ineffective. 
The effect of PLA, might be due to the action of 
free fatty acids that are released from the membrane 
phospholipids. To evaluate such a possibility, we pre- 
treated the sections with PLA, in the presence of 1% 
BSA (Goodman, 1958). The removal of free fatty 
acids by BSA prevented the increase in metabotropic 
binding, suggesting the involvement of free fatty acids 
and/or their metabolites in the action of PLA2. 
Degradation of membrane-bound phospholipids 
and production of free fatty acids occur rapidly in the 
brain after decapitation (Bazhn et al., 1971; Rehn- 
crona et al., 1982). It is possible that the differential 
effect of PLA, on binding could be ascribed to a lim- 
ited additional phospholipid breakdown by exoge- 
nously adding PLA, in some regions and not in 
others. If this were the case, however, we would expect 
an effect always in the same regions, despite the ligand 
tested. In contrast, we observed a constant increase in 
metabotropic binding in the stnatum, where no in- 
crease in AMPA binding was ever found. 
Arachidonic acid, the main product of PLA, enzy- 
matic activity, failed to mimic PLA, action and re- 
versed the enzyme effect. This result is in accord with 
the inhibiting action of arachidonic acid on PLA, ac- 
tivity (Dennis et al., 1989) and suggests that arachi- 
donic acid and, presumably, its metabolites are not 
involved in the PLA, effect. Because we could not 
wash the slices extensively after PLA, pretreatment 
without affecting the integrity of the tissue, we cannot 
exclude the possibility that the effect of PLA, was due 
to the formation of phospholipid metabolites differ- 
ent from those derived from the arachidonic cascade. 
Lysophospholipids, produced by cleavage of the 
membrane phospholipids by PLA,, could be the 
agents responsible for the PLA, effect on binding for 
their surface-active properties. Oliveira et al. (1 984) 
reported that exogeneous added lysophosphatidyl- 
choline mimics the PLA, effect on dopamine receptor 
binding in caudate nucleus microsomal membranes. 
Those authors found that albumin prevented the ef- 
fect of PLA, only when it was included in the incuba- 
tion medium, and not when it was included in the 
washing buffer. This is consistent with an action by 
lysophosphatides, which are known to be sequestered 
by albumin but not easily released from the mem- 
brane (Loh and Law, 1980). In analogy with this pre- 
vious study, our results suggest that lysophosphatides 
could mediate PLA, action on EAA binding. 
Taken together, our results indicate that PLA, mod- 
ulates the binding of AMPA and metabotropic recep- 
tors through a modification of the lipid environment 
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that surrounds the receptors. It is possible that the 
increased binding obtained following enzyme treat- 
ment in some regions but not in others is due to a 
differential interaction of the receptors with the mem- 
brane environment. This could depend on the differ- 
ential lipidic composition in different regions of the 
brain as well aLs in different parts of the neuron, but 
also on the hetlerogeneity of EAA receptor subtypes as 
demonstrated at the mRNA level. 
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